VISA / VRSA: Vancomycin-Intermediate/Resistant Staphylococcus aureus
Data & Statistics about VISA / VRSA
The following are CDC publications or publications with CDC authors reporting key data and statistics about VISA/VRSA.
Publications
- Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, U.S., 1997-2001. CID 2003
- Public Health Dispatch: Vancomycin-Resistant Staphylococcus aureus- Pennsylvania, 2002. MMWR October 2002
- Staphylococcus aureus Resistant to Vancomycin, U.S. 2002 MMWR July 2002
- Vancomycin-intermediate and resistant Staphylococcus aureus: what the infectious disease specialist needs to know. CID 2001
- Emergence of vancomycin resistance in Staphylococcus aureus. NEJM 1999
- Vancomycin-Intermediate Staphylococcus aureus in a Home Health-Care Patient. EID Journal 2001
- Staphylococcus aureus with Reduced Susceptibility to Vancomycin---Illinois, 1999.. MMWR 2000
- Staphylococcus aureus with Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal Bacteremia. EID Journal 1999
- Update: Staphylococcus aureus with Reduced Susceptibility to Vancomycin - U.S., 1997. MMWR 1997. PDF(265 KB/24 pages)
- Staphylococcus aureus with Reduced Susceptibility to Vancomycin - U.S., 1997. MMWR 1997. PDF(273 KB/24 pages)
- Reduced Susceptibility of Staphylococcus aureus to Vancomycin - Japan 1996.MMWR 1997. PDF(864 KB/3 pages)
Content source:
Division of Healthcare Quality Promotion (DHQP)
National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID)
Infection Control Topics
- Infection Control Home
- Healthcare-Associated Infections
- Protecting Patients
- Protecting Healthcare Workers
- Infection Control Guidelines
- Infection Control A-Z
- About DHQP